United States · FDA National Drug Code directory
DANZITEN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 24338-155_62029a35-74af-47bc-9b7b-93dcaddfd278
- Product NDC
- 24338-155
- Form
- TABLET
- Composition / generic term
- nilotinib
- Labeler
- Azurity Pharmaceuticals, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20241130
- Source listing expiry
- 20261231
Source-listed ingredients
- NILOTINIB — 95 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 4 CARTON in 1 CARTON (24338-155-01) / 2 BLISTER PACK in 1 CARTON (24338-155-02) / 14 TABLET in 1 BLISTER PACK (24338-155-03) · 24338-155-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →